PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Phenotype | C0740277|bile duct cancer |
| Sentences | 1 |
| PubMedID- 24868471 | However, because of frequent adverse events of the hematological system arising from these drugs and because of compromised hepatic function often noted in patients with intrahepatic bile duct cancer due to accompanying liver cirrhosis and in those with extrahepatic bile duct cancer or gallbladder cancer due to accompanying obstructive cholestasis, treatment with these drugs has to be discontinued or stopped. |
Page: 1